When sections of these archival tumor samples were stained with EMT-related antibodies, we found that fisetin and sorafenib enhanced the expression of E-cadherin (an epithelial marker protein) in xenograft tumors implanted with A375 and SK-MEL-28 melanoma cells. Here, CDH1 is linked to melanoma.